Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CON NASDAQ:FTRE NASDAQ:SGRY NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONConcentra Group Holdings Parent$21.43-3.3%$21.53$18.89▼$24.32$2.75B0.96811,232 shs511,814 shsFTREFortrea$10.10$7.40$3.97▼$25.28$919.08M1.882.30 million shs675,507 shsSGRYSurgery Partners$21.74-0.6%$22.45$18.87▼$33.90$2.80B1.761.40 million shs841,388 shsWGSGeneDx$123.25-0.6%$107.63$35.88▼$136.00$3.55B2.031.01 million shs162,095 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONConcentra Group Holdings Parent0.00%-3.95%-4.39%+4.23%-4.02%FTREFortrea0.00%-13.16%+25.62%+74.44%-52.78%SGRYSurgery Partners0.00%-2.84%-4.08%-5.61%-29.45%WGSGeneDx0.00%-6.48%-1.91%+85.30%+227.30%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONConcentra Group Holdings Parent$21.43-3.3%$21.53$18.89▼$24.32$2.75B0.96811,232 shs511,814 shsFTREFortrea$10.10$7.40$3.97▼$25.28$919.08M1.882.30 million shs675,507 shsSGRYSurgery Partners$21.74-0.6%$22.45$18.87▼$33.90$2.80B1.761.40 million shs841,388 shsWGSGeneDx$123.25-0.6%$107.63$35.88▼$136.00$3.55B2.031.01 million shs162,095 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONConcentra Group Holdings Parent0.00%-3.95%-4.39%+4.23%-4.02%FTREFortrea0.00%-13.16%+25.62%+74.44%-52.78%SGRYSurgery Partners0.00%-2.84%-4.08%-5.61%-29.45%WGSGeneDx0.00%-6.48%-1.91%+85.30%+227.30%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCONConcentra Group Holdings Parent 3.00Buy$27.5028.34% UpsideFTREFortrea 2.17Hold$11.5013.86% UpsideSGRYSurgery Partners 2.67Moderate Buy$33.0051.79% UpsideWGSGeneDx 2.75Moderate Buy$104.13-15.52% DownsideCurrent Analyst Ratings BreakdownLatest FTRE, WGS, CON, and SGRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/11/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$120.00 ➝ $140.009/9/2025FTREFortreaJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$7.00 ➝ $9.509/3/2025FTREFortreaRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$9.00 ➝ $14.008/8/2025FTREFortreaEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$5.00 ➝ $7.008/7/2025FTREFortreaBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderweight$5.00 ➝ $6.008/4/2025FTREFortreaBaird R WSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy8/4/2025FTREFortreaRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Outperform$7.00 ➝ $9.008/4/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$110.00 ➝ $120.007/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$78.00 ➝ $95.007/28/2025SGRYSurgery PartnersBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$28.007/11/2025FTREFortreaMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$8.00 ➝ $7.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCONConcentra Group Holdings Parent$2.01B1.37$1.79 per share11.99$2.20 per share9.74FTREFortrea$2.70B0.34$1.57 per share6.43$15.19 per share0.66SGRYSurgery Partners$3.24B0.86$1.86 per share11.68$25.15 per share0.86WGSGeneDx$305.45M11.59$1.02 per share121.13$8.75 per share14.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCONConcentra Group Holdings Parent$166.54M$1.1918.0216.482.027.44%50.84%5.89%10/30/2025 (Estimated)FTREFortrea-$328.50M-$11.38N/A7.89N/A-37.57%5.25%1.72%11/14/2025 (Estimated)SGRYSurgery Partners-$168.10M-$1.43N/A26.84N/A-5.57%2.51%1.01%11/11/2025 (Estimated)WGSGeneDx-$52.29M$0.052,472.5058.97N/A0.39%16.51%9.35%11/4/2025 (Estimated)Latest FTRE, WGS, CON, and SGRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025CONConcentra Group Holdings Parent$0.37$0.37N/A$0.35$537.36 million$550.80 million8/6/2025Q2 2025FTREFortrea$0.06$0.19+$0.13-$4.14$631.61 million$710.30 million8/5/2025Q2 2025SGRYSurgery Partners$0.16$0.17+$0.01-$0.02$816.96 million$826.20 million7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCONConcentra Group Holdings Parent$0.251.13%N/A21.01%N/AFTREFortreaN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ALatest FTRE, WGS, CON, and SGRY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/6/2025CONConcentra Group Holdings Parentquarterly$0.06251.2%8/21/20258/21/20258/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCONConcentra Group Holdings Parent4.751.181.18FTREFortrea1.871.021.02SGRYSurgery Partners1.101.931.78WGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCONConcentra Group Holdings ParentN/AFTREFortreaN/ASGRYSurgery PartnersN/AWGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipCONConcentra Group Holdings Parent6.60%FTREFortrea0.38%SGRYSurgery Partners2.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCONConcentra Group Holdings Parent11,250128.17 million119.71 millionN/AFTREFortrea15,50090.80 million90.46 millionOptionableSGRYSurgery Partners15,000128.21 million124.75 millionOptionableWGSGeneDx1,20028.73 million20.22 millionOptionableFTRE, WGS, CON, and SGRY HeadlinesRecent News About These CompaniesGoldman Sachs Group Inc. Cuts Stock Position in GeneDx Holdings Corp. $WGSSeptember 15 at 3:42 AM | marketbeat.comJacobs Levy Equity Management Inc. Takes $488,000 Position in GeneDx Holdings Corp. $WGSSeptember 15 at 3:19 AM | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Expected to Rise, Piper Sandler Analyst SaysSeptember 13 at 10:31 AM | marketbeat.comEllsworth Advisors LLC Acquires Shares of 15,965 GeneDx Holdings Corp. $WGSSeptember 13 at 6:52 AM | marketbeat.comGeneDx (NASDAQ:WGS) Price Target Raised to $140.00 at Piper SandlerSeptember 13 at 2:29 AM | americanbankingnews.comAssessing GeneDx Holdings: Insights From 5 Financial AnalystsSeptember 12 at 8:34 AM | benzinga.comGeneDx price target raised to $140 from $120 at Piper SandlerSeptember 11, 2025 | msn.com7,617 Shares in GeneDx Holdings Corp. $WGS Acquired by Scientech Research LLCSeptember 11, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Sets New 52-Week High - What's Next?September 10, 2025 | marketbeat.comFred Alger Management LLC Purchases 10,964 Shares of GeneDx Holdings Corp. $WGSSeptember 10, 2025 | marketbeat.comAlliancebernstein L.P. Has $38.69 Million Stock Position in GeneDx Holdings Corp. $WGSSeptember 10, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives $101.63 Average Price Target from AnalystsSeptember 9, 2025 | americanbankingnews.comGeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comPolar Asset Management Partners Inc. Has $1.73 Million Stock Holdings in GeneDx Holdings Corp. $WGSSeptember 8, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 8, 2025 | marketbeat.comGeneDx (WGS): Valuation in Focus Following Securities Investigation Triggered by Fraud AllegationsSeptember 7, 2025 | finance.yahoo.comEFG Asset Management North America Corp. Makes New $975,000 Investment in GeneDx Holdings Corp. $WGSSeptember 7, 2025 | marketbeat.comGeneDx Holdings Corp. $WGS Shares Sold by Bosun Asset Management LLCSeptember 6, 2025 | marketbeat.comComerica Bank Grows Stake in GeneDx Holdings Corp. $WGSSeptember 6, 2025 | marketbeat.comZoomInfo, International Money Express, and More Stocks See Action From Activist InvestorsSeptember 5, 2025 | msn.comGeneDx (NASDAQ:WGS) CFO Sells $47,556.18 in StockSeptember 5, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025The Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Why BitMine’s Massive Discount Could Signal a Major OpportunityBy Jeffrey Neal Johnson | August 21, 2025Tesla's Breakout: Why This Rally Looks Far From OverBy Sam Quirke | August 20, 2025FTRE, WGS, CON, and SGRY Company DescriptionsConcentra Group Holdings Parent NYSE:CON$21.43 -0.72 (-3.26%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.Fortrea NASDAQ:FTRE$10.10 0.00 (0.00%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Surgery Partners NASDAQ:SGRY$21.74 -0.13 (-0.59%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.GeneDx NASDAQ:WGS$123.25 -0.70 (-0.56%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
